Tag: Biotech

Agatica, provider of medical cashless payment app “Tamayen Pay,” raises a total of 45.8 million yen in seed round

Agatica Inc., which promotes cashless medical care, is pleased to announce that it has raised a total of…

JiMED, a developer of wireless implantable BMI system medical devices, raises 350 million yen in Series A funding

JiMED Inc., a developer of wireless implantable BMI system medical devices, has raised a total of 350 million…

Boston Medical Sciences, developer of laxative-free virtual endoscopy system, raises additional $9.3 million

Boston Medical Sciences Co., Ltd. is pleased to announce that it has raised 930 million yen in a…

PHC and CCRM Collaborate to Develop Primary T-Cell Expansion Culture Processes to Enhance Efficiency and Improve Cell Quality

PHC Corporation has signed a Master Collaboration Agreement with CCRM to work together on the development of primary…

Tensegrity Pharma, Reevaluating Drug Candidates from Unique Perspective, Raises Additional 150 Million Yen in Seed Round

Biotech startup Tensegrity Pharma announced on the 31st raising 150 million yen in seed funding. This round saw…

Neusignal Therapeutics Raises $22.5 Million in Series A Funding

Neusignal Therapeutics Inc., a Tohoku University-based company developing treatments for Alzheimer's disease, has raised 1.15 billion yen in…

KEAN Health Launches AI Search for Genetic Testing with chatGENE Pro

KEAN Health Inc. has added a new feature, "Tell me, AI Search Chat Genie," to its all-inclusive genetic…

Orizuru and Peptigrowth Develop Growth Factor Peptides

Orizuru Therapeutics Inc. and Peptigrowth Inc. are pleased to announce that they have completed the joint development of…

AlphaMeld Corporation Expands Collaboration with Kyowa Kirin

AlphaMeld Corporation, a global leader in the application of artificial intelligence (AI), machine learning (ML), and generative AI…

Guardant Health & ConcertAI Launch Data Service for Cancer R&D

Guardant Health, Inc., a leading precision oncology company, and ConcertAI, a leading oncology real-world evidence data and AI…

Daiichi Sankyo Acquires Anti-TA-MUC1 Antibody IP from Glycotope

Daiichi Sankyo Company, Ltd  announced  that it will pay Glycotope $132.5 million to acquire intellectual property rights of…

Join Our Community